February 28, 2015 10:10 PM ET


Company Overview of MSI Methylation Sciences Inc.

Company Overview

MSI Methylation Sciences Inc. operates as a biotechnology company. It develops pharmaceuticals based on molecules. The company develops and markets S-Adenosyl Methionine, a prescription drug used as a dietary supplement. MSI Methylation Sciences Inc. was founded in 2007 and is based in Burnaby, Canada.

4475 Wayburne Drive

Unit 108

Burnaby, BC V5G 4X4


Founded in 2007





Key Executives for MSI Methylation Sciences Inc.

President and Chief Executive Officer
Age: 58
Age: 49
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Worldwide Marijuana Inc. Americas
Valeant Canada Ltd. Americas
Sandoz Canada Inc. Americas
CinG-X Corporation Americas
Diabetogen Biosciences, Inc. Americas

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MSI Methylation Sciences Inc., please visit www.methylationsciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.